Kaléo announced that Auvi-Q (epinephrine injection) Auto-injector will be available in pharmacies beginning February 14th. 

Auvi-Q Auto-injector is approved to treat life-threatening allergic reactions, including anaphylaxis, in patients who are at risk for or have a history of serious allergic reactions. The epinephrine auto-injector features voice instructions that guide the user with step-by-step instructions through the delivery process. It also features an automatic retractable needle system that retracts the needle back into the device within seconds of administration. 

Related Articles

The Company also announced a first-of-its-kind access program, Auvi-Q Afford Ability, which will provide patients with commercial insurance an out-of-pocket cost of $0. For patients without government or commercial insurance who have a household income of less than $100,000, Auvi-Q will be available free of charge; the cash price for Auvi-Q is $360. Auvi-Q will also be available as a direct delivery service.

Auvi-Q will be available as 0.15mg and 0.3mg strength auto-injectors. Each package contains 2 auto-injectors and 1 trainer injector.

For more information call (877) 302-8847 or visit Auvi-Q.com.